key facts
| Fact | Details |
|---|---|
| Company Overview | Gland Pharma Limited is an Indian pharmaceutical company specializing in generic injectables. |
| Financial Performance | Gland Pharma’s revenue for FY 2023 stood at ₹3865 crore, with a net profit of ₹781 crore. |
| Market Presence | Gland Pharma operates in over 60 countries, with a strong focus on regulated markets like the US and Europe. |
| Product Portfolio | Gland Pharma’s product portfolio includes injectables, ophthalmics, dermatologicals, and more. |
Company Overview
Gland Pharma Limited is a leading Indian pharmaceutical company renowned for its expertise in generic injectables. With a commitment to quality and innovation, Gland Pharma has established itself as a trusted provider of essential healthcare solutions. Gland Pharma’s financial performance reflects its resilience and growth trajectory in the competitive pharmaceutical industry. In FY 2023, the company reported robust revenue of ₹3865 crore, accompanied by a net profit of ₹781 crore, showcasing its strong financial fundamentals and operational efficiency.
Product Portfolio
Gland Pharma’s extensive product portfolio encompasses a wide range of therapeutic categories, including injectables, ophthalmics, dermatologists, and more. With a focus on innovation and customer-centricity, Gland Pharma continually expands its product offerings to address evolving healthcare needs and market demands.
Exploring Investment Opportunities
Investing in Gland Pharma unveils promising opportunities for investors seeking exposure to India’s pharmaceutical sector. With a proven track record of success and a commitment to excellence, Gland Pharma positions itself as a compelling investment choice, offering the potential for long-term growth and value creation.
Explore Gland Pharma Today!
Are you eager to capitalize on the promising prospects offered by Gland Pharma? Dive into the world of pharmaceutical investments with confidence, guided by precision screeners that unravel the company’s growth potential and market dynamics.
Value Stocks with 6 Different Valuation Methods is an invaluable tool designed to analyze and value stocks in the Indian market. Whether you’re a seasoned investor or a novice, this Excel file provides insights derived from six different valuation methods, empowering you to make informed investment decisions. Master stock valuation and elevate your investment strategy with this comprehensive resource.
Run the numbers yourself. Our 6-in-1 stock valuation Excel file computes DCF, Ben Graham, Dhandho and 3 more methods for any Indian stock, straight from your Screener.in export. It is free until August 31, 2026. Get the sheet.
